Quirant-Sánchez, B.; Mansilla, M.J.; Navarro-Barriuso, J.; Presas-RodrÃguez, S.; Teniente-Serra, A.; Fondelli, F.; Ramo-Tello, C.; MartÃnez-Cáceres, E.
Combined Therapy of Vitamin D3-Tolerogenic Dendritic Cells and Interferon-β in a Preclinical Model of Multiple Sclerosis. Biomedicines 2021, 9, 1758.
https://doi.org/10.3390/biomedicines9121758
AMA Style
Quirant-Sánchez B, Mansilla MJ, Navarro-Barriuso J, Presas-RodrÃguez S, Teniente-Serra A, Fondelli F, Ramo-Tello C, MartÃnez-Cáceres E.
Combined Therapy of Vitamin D3-Tolerogenic Dendritic Cells and Interferon-β in a Preclinical Model of Multiple Sclerosis. Biomedicines. 2021; 9(12):1758.
https://doi.org/10.3390/biomedicines9121758
Chicago/Turabian Style
Quirant-Sánchez, Bibiana, MarÃa José Mansilla, Juan Navarro-Barriuso, Silvia Presas-RodrÃguez, Aina Teniente-Serra, Federico Fondelli, Cristina Ramo-Tello, and Eva MartÃnez-Cáceres.
2021. "Combined Therapy of Vitamin D3-Tolerogenic Dendritic Cells and Interferon-β in a Preclinical Model of Multiple Sclerosis" Biomedicines 9, no. 12: 1758.
https://doi.org/10.3390/biomedicines9121758
APA Style
Quirant-Sánchez, B., Mansilla, M. J., Navarro-Barriuso, J., Presas-RodrÃguez, S., Teniente-Serra, A., Fondelli, F., Ramo-Tello, C., & MartÃnez-Cáceres, E.
(2021). Combined Therapy of Vitamin D3-Tolerogenic Dendritic Cells and Interferon-β in a Preclinical Model of Multiple Sclerosis. Biomedicines, 9(12), 1758.
https://doi.org/10.3390/biomedicines9121758
